S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
KRMD · KORU Medical Systems, Inc. Common Stock (DE)
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
KORU Medical Systems Inc (KRMD)
NASDAQ NMS - GLOBAL MARKET
Health Care
$3.11
+0.06
(+2.13%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$3.11
$3.03
$3.15
52-WEEK RANGE
$3.11
$2.86
$6.61
What's happening
- KRMD is up 2.13% today, trading at $3.11. — Live quote
- Volume today (7,435) is well below its 3-month average of 219,570. (Finnhub fundamentals)
- Reports earnings on 2026-11-11 (after market close), 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.01 actual vs. $-0.02 estimated (+170.7%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 6
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
KRMD
-47.68%
vs S&P 500
-60.45%
1-YEAR RETURN
KRMD
-26.57%
vs S&P 500
-41.13%
6-MONTH RETURN
KRMD
-27.27%
3-MONTH RETURN
KRMD
-24.57%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.01
Est. $-0.02
BEAT +170.7%
2026-04-26 (Q1 2026)
$-0.02
Est. $-0.02
BEAT +2.0%
2026-01-26 (Q4 2025)
$-0.01
Est. $-0.02
BEAT +50.5%
2025-10-26 (Q3 2025)
$-0.02
Est. $-0.03
BEAT +30.1%
Valuation Measures & Ratios
Enterprise Value4$132.3M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)3.11
Price / Book710.69
EV4 / Revenue2.93
EV4 / EBITDA944.96
Profit Margin-4.03%
Operating Margin-3.66%
Return on Equity (ROE8)-10.63%
Return on Assets (ROA9)-6.51%
Avg Volume (3M)219,570
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $104.9M | $174.1M | — | — | $99.3M |
| P/E | -68.14 | -58.86 | — | — | -17.51 |
| Price/Sales | 2.36 | 4.15 | — | — | 2.88 |
| Price/Book | 5.81 | 10.29 | — | — | 6.08 |
| EV/Revenue | 2.18 | 3.94 | — | — | 2.63 |
| EV/EBITDA | -161.89 | -67.18 | — | — | — |
| ROE | -8.53% | -17.48% | — | — | -34.70% |
| ROA | -5.51% | -10.35% | — | — | -20.84% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short907,388
Change from Prior Settlement-7.84%
% of Float—
Days to Cover (Short Ratio)2.54
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 18.1% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-01; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -4.0%. Finnhub fundamentals ↗
- Trailing 52-week price return is -26.6%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on KRMD
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.0M | $11.8M | $10.4M | $10.2M | $9.6M | $8.2M | $8.4M | $8.2M |
| Gross profit | $7.8M | $7.2M | $6.3M | $6.5M | $6.0M | $5.2M | $5.5M | $5.1M |
| Operating income | $627.0K | -$864.9K | -$867.7K | -$312.7K | -$1.2M | -$1.7M | -$1.2M | -$2.0M |
| Net income | $252.4K | -$807.1K | -$778.0K | -$206.9K | -$1.2M | -$1.6M | -$988.7K | -$1.9M |
| EPS (diluted) | $0.01 | $-0.02 | $0.02 | $0.00 | $-0.03 | $0.03 | $0.02 | $0.04 |
| EPS (basic) | $0.01 | $-0.02 | — | $0.00 | $-0.03 | $-0.03 | $-0.02 | $0.04 |
| Operating margin | $5 | -$7 | -$8 | -$3 | -$13 | -$21 | -$14 | -$24 |
| Net margin | $2 | -$7 | -$7 | -$2 | -$12 | -$19 | -$12 | -$24 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $28.0M | $28.6M | $28.2M | $27.1M | $25.5M | $27.2M | $27.2M | $27.4M |
| Total liabilities | $9.9M | $11.7M | $11.2M | $10.6M | $9.0M | $10.9M | $10.4M | $9.7M |
| Stockholders' equity | $18.1M | $16.9M | $17.0M | $16.5M | $16.5M | $16.3M | $16.8M | $17.7M |
| Total current assets | $19.5M | $20.6M | $20.0M | $19.4M | $17.6M | $19.0M | $19.1M | $18.9M |
| Total current liabilities | $7.2M | $8.9M | $8.2M | $7.8M | $6.1M | $7.8M | $7.2M | $6.3M |
| Cash & equivalents | $8.3M | $8.8M | $8.9M | $8.5M | $8.1M | $8.7M | $9.6M | $8.8M |
| Accounts receivable | $5.0M | — | $6.0M | — | — | — | — | — |
| Inventory | $4.5M | $4.5M | $3.7M | $4.4M | $3.9M | $3.3M | $2.8M | $3.9M |
| Property, plant & equipment | $3.9M | $4.3M | $4.5M | $4.2M | $4.4M | $4.5M | $4.3M | $4.6M |
| Intangible assets | $1.7M | $711.2K | $684.8K | $681.6K | $699.0K | $716.3K | $730.3K | $746.3K |
| Other non-current assets | $99.0K | $99.0K | $99.0K | $99.0K | $99.0K | $99.0K | $99.0K | $99.0K |
| Accounts payable | $2.9M | $2.6M | $2.3M | $1.9M | $1.1M | $2.0M | $1.6M | $1.7M |
| Accrued liabilities | $2.9M | $5.3M | $4.8M | $4.6M | $3.6M | $4.0M | $3.9M | $2.8M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | $11.1K | $11.1K | $27.7K | $2.9K | $104.1K | $110.1K | $29.3K | $181.7K |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $501.7K | $499.3K | $497.9K | $497.1K | $496.6K | $495.6K | $493.8K | $492.8K |
| Retained earnings | -$32.6M | -$32.8M | -$32.0M | -$31.5M | -$30.8M | -$30.5M | -$29.4M | -$27.8M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $216.1K | $14.7K | $1.1M | $65.5K | -$460.3K | -$237.5K | $939.6K | -$923.9K |
| Investing cash flow | -$577.4K | -$89.9K | -$421.7K | -$52.5K | -$28.8K | -$446.8K | $50.7K | -$1.1M |
| Financing cash flow | -$118.8K | -$29.2K | -$264.9K | $396.3K | -$192.0K | -$160.8K | -$215.7K | $374.5K |
| Capital expenditures | — | — | — | — | — | — | — | — |
| Depreciation & amortization | $210.0K | $197.5K | $593.1K | $204.5K | $209.5K | $217.4K | $657.1K | $227.8K |
| Share-based compensation | $457.8K | $681.5K | $972.8K | $627.4K | $415.7K | $697.6K | $699.8K | $609.7K |
| Deferred income taxes | — | — | — | -$150 | $17.4K | $0 | — | $0 |
| Change in accounts receivable | -$717.1K | -$227.4K | $797.9K | $496.4K | -$1.0M | $228.7K | $556.0K | -$681.4K |
| Change in inventory | $34.8K | $798.2K | -$733.6K | $463.9K | $669.2K | $475.0K | -$1.1M | $1.3M |
| Change in accounts payable | $276.9K | $368.2K | $395.3K | $777.6K | -$919.0K | $363.6K | -$20.3K | $74.6K |
| Share repurchases | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $81.1K | — | — | — | $27.5K | — | — | — |
| Other financing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $41.1M | $33.6M | $28.5M | $27.9M | $23.5M |
| Gross profit | $25.6M | $21.3M | $16.7M | $15.4M | $13.8M |
| Operating income | -$3.0M | -$6.4M | -$10.3M | -$10.8M | -$7.0M |
| Net income | -$2.6M | -$6.1M | -$13.7M | -$8.7M | -$4.6M |
| EPS (diluted) | $-0.06 | $-0.13 | $-0.30 | $-0.19 | $-0.10 |
| EPS (basic) | $-0.06 | $-0.13 | $-0.30 | $-0.19 | $-0.10 |
| Operating margin | -$7 | -$19 | -$36 | -$39 | -$30 |
| Net margin | -$6 | -$18 | -$48 | -$31 | -$19 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $28.2M | $27.2M | $28.5M | $42.3M | $41.3M |
| Total liabilities | $11.2M | $10.4M | $8.1M | $11.0M | $4.8M |
| Stockholders' equity | $17.0M | $16.8M | $20.4M | $31.3M | $36.5M |
| Total current assets | $20.0M | $19.1M | $20.3M | $29.8M | $37.3M |
| Total current liabilities | $8.2M | $7.2M | $4.5M | $7.0M | $4.8M |
| Cash & equivalents | $8.9M | $9.6M | $11.5M | $17.4M | $25.3M |
| Accounts receivable | — | — | — | — | — |
| Inventory | $3.7M | $2.8M | $3.5M | $6.4M | $6.1M |
| Property, plant & equipment | $4.5M | $4.3M | $3.8M | $3.9M | $1.1M |
| Intangible assets | $684.8K | $730.3K | $754.4K | $787.2K | $808.8K |
| Other non-current assets | $99.0K | $99.0K | $99.0K | $102.6K | $19.8K |
| Accounts payable | $2.3M | $1.6M | $975.2K | $2.4M | $1.2M |
| Accrued liabilities | $4.8M | $3.9M | $1.7M | $2.9M | $2.7M |
| Short-term debt | — | — | — | — | — |
| Other current liabilities | $27.7K | $29.3K | $512.5K | $257.3K | $90.0K |
| Long-term debt | — | — | — | — | — |
| Common stock & paid-in capital | $497.9K | $493.8K | $490.9K | $488.6K | $480.4K |
| Retained earnings | -$32.0M | -$29.4M | -$23.3M | -$9.6M | -$910.1K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $462.4K | -$319.7K | -$4.9M | -$5.4M | -$4.3M |
| Investing cash flow | -$949.8K | -$1.3M | -$814.6K | -$2.8M | -$366.2K |
| Financing cash flow | -$221.3K | -$248.5K | -$218.9K | $279.5K | $2.7M |
| Capital expenditures | — | — | — | — | — |
| Depreciation & amortization | $810.5K | $888.5K | $870.4K | $587.1K | $463.1K |
| Share-based compensation | $2.7M | $2.6M | $2.8M | $3.1M | $2.7M |
| Deferred income taxes | — | — | -$4.0M | — | — |
| Change in accounts receivable | $489.2K | $1.7M | $486.3K | -$34.0K | $1.0M |
| Change in inventory | $874.5K | -$677.6K | -$2.9M | $298.5K | -$723.4K |
| Change in accounts payable | $617.5K | $674.8K | -$1.4M | $1.2M | $602.6K |
| Share repurchases | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding KRMD as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-04-01 to 2026-10-01
Recent transactions
- Insiders have net bought 61,191 shares over the last 182 days, across 8 purchases and 0 sales.
- Most recent: CASCELLA ROBERT (Director) — Grant / award of 5,119 shares on 2026-10-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)61,191 sh(8 txns)
Sales (open market)0 sh(0 txns)
Net Shares+61,191
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| CASCELLA ROBERT | Director | Grant / award | 2026-10-01 | 5,119 |
| Matin Shahriar | Director | Grant / award | 2026-10-01 | 5,119 |
| FLETCHER R JOHN | Director | Grant / award | 2026-10-01 | 7,679 |
| WHOLIHAN EDWARD | Director | Grant / award | 2026-10-01 | 5,119 |
| French Donna | Director | Grant / award | 2026-10-01 | 5,119 |
| Manko Joseph M. Jr. | Director | Grant / award | 2026-09-30 | 5,119 |
| KALBERMATTEN ADAM R | Chief Commercial Officer | Open market purchase | 2026-09-08 | 32,000 |
| Schiller Eric | Chief Technology Officer | Open market purchase | 2026-05-18 | 5,000 |
| Tharby Linda M | Chief Executive Officer | Open market purchase | 2026-05-15 | 1,191 |
| Pazdan Christopher | Chief Operating Officer | Option exercise | 2026-05-14 | 5,327 |
| Adams Thomas Edward | Chief Financial Officer | Option exercise | 2026-05-14 | 8,193 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | CASCELLA ROBERT | Director | Grant / award | 5,119 | $2.93 |
| 2026-10-01 | Matin Shahriar | Director | Grant / award | 5,119 | $2.93 |
| 2026-10-01 | FLETCHER R JOHN | Director | Grant / award | 7,679 | $2.93 |
| 2026-10-01 | WHOLIHAN EDWARD | Director | Grant / award | 5,119 | $2.93 |
| 2026-10-01 | French Donna | Director | Grant / award | 5,119 | $2.93 |
| 2026-09-30 | Manko Joseph M. Jr. | Director | Grant / award | 5,119 | $0.00 |
| 2026-09-08 | KALBERMATTEN ADAM R | Chief Commercial Officer | Open market purchase | 32,000 | $3.16 |
| 2026-07-28 | KALBERMATTEN ADAM R | Chief Commercial Officer | Option exercise | 75,000 | $0.00 |
| 2026-07-28 | KALBERMATTEN ADAM R | Chief Commercial Officer | Tax withholding | 25,483 | $4.26 |
| 2026-07-01 | WHOLIHAN EDWARD | Director | Grant / award | 3,571 | $4.20 |
| 2026-07-01 | Matin Shahriar | Director | Grant / award | 3,571 | $4.20 |
| 2026-07-01 | French Donna | Director | Grant / award | 3,571 | $4.20 |
| 2026-07-01 | FLETCHER R JOHN | Director | Grant / award | 5,357 | $4.20 |
| 2026-07-01 | CASCELLA ROBERT | Director | Grant / award | 3,571 | $4.20 |
| 2026-06-30 | Manko Joseph M. Jr. | Director | Grant / award | 3,571 | $0.00 |
| 2026-06-11 | KALBERMATTEN ADAM R | President-Chief Commercial Off | Open market purchase | 5,000 | $3.96 |
| 2026-06-11 | KALBERMATTEN ADAM R | President-Chief Commercial Off | Open market purchase | 7,500 | $3.93 |
| 2026-05-18 | Schiller Eric | Chief Technology Officer | Open market purchase | 5,000 | $3.91 |
| 2026-05-15 | Tharby Linda M | Chief Executive Officer | Open market purchase | 1,191 | $1191.00 |
| 2026-05-14 | Tharby Linda M | Chief Executive Officer | Option exercise | 13,977 | $0.00 |
| 2026-05-14 | Tharby Linda M | Chief Executive Officer | Tax withholding | 7,326 | $3.94 |
| 2026-05-14 | Pazdan Christopher | Chief Operating Officer | Option exercise | 5,327 | $0.00 |
| 2026-05-14 | Pazdan Christopher | Chief Operating Officer | Tax withholding | 1,470 | $3.94 |
| 2026-05-14 | Pazdan Christopher | Chief Operating Officer | Open market purchase | 5,000 | $3.88 |
| 2026-05-14 | Adams Thomas Edward | Chief Financial Officer | Option exercise | 8,193 | $0.00 |
| 2026-05-14 | Adams Thomas Edward | Chief Financial Officer | Tax withholding | 2,900 | $3.94 |
| 2026-05-14 | Adams Thomas Edward | Chief Financial Officer | Open market purchase | 5,041 | $3.86 |
| 2026-05-14 | Adams Thomas Edward | Chief Financial Officer | Open market purchase | 459 | $3.90 |
| 2026-04-01 | Matin Shahriar | Director | Grant / award | 3,472 | $4.32 |
| 2026-04-01 | French Donna | Director | Grant / award | 3,472 | $4.32 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:13 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-01 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-10-01 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-01 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-01 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-01 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-10-01 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-09-09 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-08-14 | 8-K | 2026-08-13 | View on SEC.gov → |
| 2026-08-06 | 4 | 2026-07-28 | View on SEC.gov → |
| 2026-08-05 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-05 | 8-K | 2026-08-05 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-07-01 | View on SEC.gov → |
Recent news
Headlines about KRMD (KORU Medical Systems, Inc. Common Stock (DE)). Links open the publisher — we don’t host full articles.
-
KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026
Yahoo · 2026-10-20 -
KRMD Oct 2026 2.500 put (KRMD261016P00002500) interactive stock chart
Yahoo Finance UK · 2026-10-18 -
Reasons to Retain Doximity Stock in Your Portfolio for Now
Yahoo Finance · 2026-10-05 -
KORU Medical Systems Selloff Offers An Opportunity
Seeking Alpha · 2026-08-22 -
KORU (KRMD) Q2 2026 Earnings Call Transcript
Yahoo Finance · 2026-08-12 -
KORU Medical Systems Inc (KRMD) (Q2 2026) Earnings Call Highlights: Record Revenue and First ...
Yahoo Finance · 2026-08-06 -
KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript
Seeking Alpha · 2026-08-06 -
KORU Medical Systems, Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha · 2026-08-05
No headlines in this category right now — try “All”.